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Abstract: 
 
We investigated the ability of exercise, a multipathway, potent, physiological stimulus for GH 
release, to alter the synergistic interaction of l-arginine (A) and GH-related peptide (GHRP)-2 
(G) observed at rest and the ability of gender to further modulate this putative interaction. 
Subjects (9 men and 9 early follicular phase women) completed 30 min of constant load aerobic 
exercise in combination with intravenous infusions of saline (S), A (30 g over 30 min), G (1 
μg/kg bolus), or both (AG) in separate study sessions in randomly assigned order. Measures of 
GH release were logarithmically transformed for statistical analysis. Similar to rest, exercise 
maintained the rank order (AG > G > A > S) of effective stimulation of GH release for the key 
response measures in men or women, a gender disparity in the time to reach the maximal serum 
GH concentration, the calculated endogenous GH half-life, and the observed effect of 
preinfusion (basal) serum GH concentrations on determining secretagogue responsiveness. 
Exercise potentiated the individual stimulatory actions of A and G, while blunting the relative 
magnitude of the synergistic (supra-additive) interaction observed at rest. We infer from the 
present data that 1) exercise is likely to induce release of both GHRH and somatostatin, 2)l-
arginine may facilitate the effect of exercise by limiting somatostatin release, 3) GHRP-2 could 
further enhance the stimulatory impact of exercise by opposing central actions of somatostatin 
and/or heightening endogenous GHRH release, and4) gender strongly controls the relative but 
not absolute magnitude of A/G synergy both at rest and after exercise. 
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Article: 
 
Exercise is a potent physiological stimulus for growth hormone (GH) release in both sexes 
(22, 23, 31, 41, 42, 44). Although the neuroendocrine basis underlying exercise-induced GH 
release remains enigmatic, the mechanism would putatively involve GH-releasing hormone 
(GHRH) release and/or somatostatin withdrawal and possibly natural GH-releasing peptide 
(GHRP)-like ligand release or a combination of these mechanisms (18). Application of relevant 
neurophysiological probes, such as the selective GH secretagogues l-arginine (A) and/or GHRP-
2 (G), may help clarify the neuroendocrine pathway of the exercise stimulus. As reviewed further 
in the discussion, we reason that if exercise-induced GH release is preferentially mediated by 
somatostatin withdrawal, then stimulation with A and exercise should evoke equivalent and 
nonadditive (combined stimuli) responses for GH release. Analogously, if the exercise stimulus 
depends on release of a putative natural GHRP-like ligand, then the response to exercise and a 
potent GHRP (e.g., G) should be similar and their combination noninteractive. Conversely, if 
GHRH is involved as a primary mediator of exercise-induced GH release, then exercise 
combined with A and/or exercise combined with G should elicit greater GH release then exercise 
alone. The latter conjecture is based on the synergy observed at rest between GHRP and 
exogenous GHRH (5, 7, 28, 29), and the interpretation that presumptive release of endogenous 
GHRH by exercise could also synergize with infused G. Accordingly, here we have investigated 
the impact of A and/or G infusions on exercise-induced GH release. This strategy thereby 
assesses indirectly the various mechanistic contributions of endogenous somatostatin withdrawal 
and GHRH (and/or putative GHRP-like ligand) release to exercise-driven GH secretion in men 
and women. 
 
Strong gender distinctions in GH neuroregulation are evident in experimental animals and the 
human (18). Thus we postulated that gender further influences the effects of A and/or G on 
exercise-induced GH release. Although gender differences in responses to several GH 
stimulation tests have been reported (1, 18, 21,25), results of gender comparisons in the limited 
available studies with GHRPs have been controversial (2, 4, 27). In corollary, whereas A and 
GHRP are equally synergistic in both genders studied at rest (companion paper, Ref. 43), the 
sex-dependency of their interaction with exercise (if any) is not known. Accordingly, here we 
also explore how gender modulates the interaction between exercise and A or G actions, 
considered alone and combined. We hypothesized that gender disparities in GH secretory 
responses to one or both of the secretagogues observed at rest would be effaced by a (potentially 
multipathway) exercise stimulus. 
 
METHODS 
 
The detailed methodology associated with the resting component (control) of the present study is 
described fully in the companion paper (43). In the present continuation, we also examined the 
effects of exercise on GH release. For this paper, the following additional methods were 
employed. 
 
Subjects completed a peak oxygen consumption (V˙o2)/lactate threshold test on an electronically 
braked cycle ergometer (Ergo Metrics 800S). Initial power output (PO) was 40 W for women 
and 60 W for men, and the PO was increased 15 W every 3 min until volitional fatigue. 
Metabolic measures were collected using standard open-circuit spirometric techniques 
(Sensormedics metabolic cart 2700Z, Yorba Linda, CA). Heart rate was determined 
electrocardiographically. An indwelling venous cannula was inserted in a forearm vein, and 
blood samples were taken at rest and during the last 15 s of each exercise stage for the 
measurement of blood lactate concentration (YSI Instruments 2700, Yellow Springs, OH). The 
lactate threshold (LT) was determined from the blood lactate-PO relationship (40). The PO for 
the 30 min constant load (CL) aerobic exercise sessions (CLPO) was calculated as follows 
 
CLPO = PO at LT + 0.50(PO at VO2peak − PO at LT) 
 
Subjects were evaluated in the General Clinical Research Center on four other occasions 
(exercise). The four stimuli described earlier were applied [saline (S); A alone (30 g iv over 30 
min); G alone (1 μg/kg iv bolus); A and G combined] immediately before the 30-min CL 
exercise bout (0800–0830). Subjects began exercise at the predetermined CLPO, but all subjects 
were advised that completing 30 min of exercise was more important than remaining at the 
predetermined CLPO. All decreases in PO were noted, and total work for each admission was 
calculated as the sum of PO over the 30-min exercise session. Metabolic measures were 
collected on a minute-by-minute basis, and total number of calories expended during the 30 min 
CL exercise session was calculated as the sum of the minute values. Heart rate was measured 
during exercise and was analyzed at 10, 20, and 30 min of exercise. Blood lactate concentrations 
were measured at 10, 20, and 30 min of exercise. All admissions (n = 8; 4 rest, 4 exercise) were 
randomly ordered and scheduled at least 2 days apart. Women were studied during the early 
follicular phase (days 2–8) of the menstrual cycle, and hence across two or more menstrual 
cycles to accommodate all eight sessions. 
 
A full description of the statistical methodology was described in the companion paper (43). 
Briefly, data for serum sex steroids, insulin-like growth factor (IGF)-1, integrated GH [area 
under the curve (AUC)], and calculated secretion parameters were analyzed by three-way nested 
ANOVA, with gender, condition (rest vs. exercise), and stimulus type considered as 
classification variables. Nonadditivity data were analyzed by a two-way nested ANOVA, with 
gender and condition as classification variables. Regression analysis was used to assess the 
relationship between maximal serum GH concentrations (independent variable) and GH half-life 
(dependent variable). 
 
RESULTS 
 
Regardless of the stimulus administered before exercise (saline, A, and/or G), there was no 
difference in end-exercise blood lactate, end-exercise V˙o2, total kilocalories, and total work in 
response to the 30-min constant load (CL) exercise bout (Table 1). Men had greater absolute 
V˙o2 values [1.4-fold, 95% CL(1.1,1.65),P = 0.007] and total energy expenditure [1.3-fold, 95% 
CL(1.0–1.55), P = 0.026] compared with women. When end-exercise V˙o2 was adjusted for fat-
free mass (ml · kg fat free mass−1 · min−1), there was no significant gender difference in this 
measure. Independent of sex, there was a trend (P = 0.051) for heart rate to be higher during the 
S and A admissions compared with the G and AG admissions. There was also a trend for men to 
have a greater total work output than women during the 30-min CL exercise bout (P= 0.076). 
 
 
 
 
 
Table 1. Gender comparisons for 30-min constant load aerobic exercise 
 
 
 
Fig. 1. Mean serum growth hormone (GH) concentration (μg/l) profiles basally and in response 
to GH releasing peptide-2 (G) and/orl-arginine (A) infusions in men (A) and women (B). Data 
are the means ± SE. Clock time (h) is shown. 
 
The mean GH response patterns after each stimulus are shown in Fig. 1A for men and Fig. 1B for 
women. The maximal serum GH concentration attained was greatest for the AG stimulus and 
least for S. As observed in the resting (R) condition (companion paper, Ref. 43), the rank order 
of stimulus strength (AG > G > A > S) was similar in men and women. Regardless of the single 
or combined stimulus administered, the absolute maximal serum GH concentration attained with 
exercise was greater than that observed at rest (see Fig. 1 of companion paper, Ref. 43). In men, 
the maximal serum GH concentrations attained after each stimulus combined with exercise was 
14, 25, 101, and 116 μg/l (for S, A, G, and AG, respectively); the corresponding values for 
women were 20, 32, 105, and 143 μg/l (for S, A, G, and AG, respectively). These data represent 
a 48 (men)- and 23-fold (women) increase in the maximal serum GH concentration in response 
to AG combined with exercise compared with resting saline control (i.e., 2.4 and 6.1 μg/l for 
men and women, respectively). The maximal serum GH concentration attained in response to the 
secretagogue administered was significantly influenced by gender (P = 0.016) and condition (rest 
vs. exercise, P < 0.001). Additionally, the incremental change associated with the exercise vs. 
rest condition was significantly influenced by gender (P = 0.009). 
 
 
Fig. 2. Representative serum GH concentration profiles (A) in an individual healthy young man 
and woman basally and in response to G and/or A infusions and the corresponding (calculated) 
GH secretion profiles (B). Time zero corresponds to 0600 clock time in Fig. 1. GHRP, GH 
releasing peptide. 
 
In women, the time to reach maximal serum GH concentration was longer after the A and AG 
stimuli (60 min) compared with G (30 min). A significant latency was also observed in men, but 
was greater than in women for the A and G stimuli (70 and 40 min, respectively), but similar for 
the combined AG stimulus (60 min). The time to reach the maximal serum GH concentration 
was dependent on gender (P < 0.001) and stimulus administered (P < 0.001), but independent of 
the rest vs. exercise condition (P = 0.272). 
 
Representative individual serum GH concentration vs. time curves for a man and woman are 
illustrated in Fig. 2A, and the corresponding (calculated) GH secretion profiles assessed by 
deconvolution analysis are given in Fig. 2B (discussed below). 
 
Figure 3 presents a box plot summarizing values of total serum (6 h) GH AUC for men and 
women in response to each stimulus during exercise. The gradation of the responses of serum 
GH AUC (AG > G > A > S) was similar to that obtained at rest and the same for men and 
women. The increase in serum GH AUC for the AG stimulus combined with exercise compared 
with S (resting control) was 31-fold for men and 15-fold for women. The incremental change in 
serum GH AUC observed after stimulus administration was influenced significantly by gender 
(P < 0.001) and condition (rest vs. exercise) (P = 0.007). In both men and women, exercise 
elevated significantly the serum GH AUC compared with rest for the S and G stimuli (P < 0.001 
for both), but not for AG. With the A infusion, exercise resulted in significantly greater serum 
GH AUC compared with rest in men (P < 0.001), but not women. In both women and men, the 
fold increase observed in GH AUC for the AG stimulus compared with control was greater 
during exercise than at rest (31-fold vs. 24-fold in men; 15-fold vs. 11-fold for women). When 
the results for serum GH AUC were combined for men and women during exercise, responses to 
the A or G stimulus given alone were significantly greater than the S stimulus (P < 0.001 for 
both), but AG compared with G was not significantly different. Exercise alone (saline infusion 
with exercise) and A infusion alone without exercise exerted equivalent effects on GH AUC. 
 
 
Fig. 3. Box plot representations of log[integrated serum GH area under curve (AUC)] basally 
and in response to G and/or A infusions in healthy young men and women. ○, Single 
measurements below the 10th or above the 90th percentile. 
 
Figure 4 presents a box plot summarizing values of 90-min GH secretory burst mass. This 
measure reflects stimulus-driven secretion after correction for half-life. A graded stimulus order 
was observed for 90-min GH secretory burst mass (AG > G > A > S) in both genders. The 
increase in 90-min GH secretory burst mass for the AG stimulus combined with exercise relative 
to the S stimulus at rest was 362-fold for men and 55-fold for women. Men and women had 
similar absolute values of 90-min GH secretory burst mass after the combined exercise/AG 
stimulus (252 vs. 248 μg/l). Although 90-min GH secretory burst mass tended to be greater in 
women than men after exercise combined with S infusion (36.4 vs. 15.7 μg/l), A infusion (73.4 
vs. 41.5 μg/l), or G infusion (198 vs. 161 μg/l), none of the differences was statistically 
significant. The incremental changes in 90-min GH secretory burst mass after secretagogue 
infusions were significantly influenced by gender (P = 0.005) and condition (rest vs. exercise) 
(P < 0.001). In men and women, the fold change in 90-min GH secretory burst mass for the AG 
compared with the S stimulus was greater with exercise (363-fold for men and 55-fold for 
women) than at rest (242-fold for men and 40-fold for women). When absolute 90-min secretory 
burst mass values were combined in men and women, neither comparison of A infusion vs. 
control (S) nor AG vs. G stimulus showed significant differences during exercise. As was 
observed for GH AUC, GH pulse mass after exercise alone (saline infusion) and A infusion 
alone (no exercise) were not significantly different. 
 
 
Fig. 4. Box plot representations of log(90-min GH secretory burst mass) during saline infusion 
and in response to G and/or A infusions in healthy young men and women. ○, Occasional 
measurements below the 10th or above the 90th percentile. 
 
The order of magnitude of endogenous GH production rates (over 6 h) was the same for men and 
women (AG > G > A > S) and identical to that observed at rest (companion paper, Ref. 43). 
Women tended to have a greater endogenous GH production rate than men for each stimulus, but 
these differences were nonsignificant (Table 2). The fold change in endogenous GH production 
rate for the AG stimulus combined with exercise compared with control (S at rest) was 38-fold 
for men and 10-fold for women. The increase stimulated by AG was greater during exercise than 
rest in men (38- and 25-fold), but similar in women (10- and 7-fold). The fold change in 
endogenous GH production rate associated with secretagogue administered was significantly 
influenced by gender (P< 0.001) and condition (P = 0.017). Additionally, the incremental change 
associated with the exercise vs. rest condition was significantly influenced by gender (P = 
0.044). 
 
Table 2. Gender comparisons for calculated GH secretion measures 
 
 
Although the number of GH peaks detected per 6 h by deconvolution analysis tended to be 
greater in women than men in response to the S, A, and G stimuli, none of the differences was 
significant (data not shown, range = 4–6). Men and women had a similar number of GH peaks 
after the AG stimulus. However, stimulus type interacted with gender in influencing the number 
of GH peaks (P = 0.011). 
 
There were no significant gender, stimulus, or condition (rest vs. exercise) differences in fasting 
serum concentrations of estradiol or IGF-1. Men had significantly higher total and free 
testosterone concentrations (P < 0.001, for both), independent of condition (P = 0.570 and P = 
0.539, respectively) and stimulus type (P = 0.512 andP = 0.560, respectively). 
 
When the test of nonadditivity was applied to stimulated GH AUC during exercise, the joint AG 
infusion was synergistic (i.e., supra-additive), compared with the summed individual effects of A 
and G (A + G) (P = 0.003). The difference between AG and the summed individual effects (A + 
G) in the both genders was small, 1.1-fold for women [95% CL(0.9,1.4)] and 1.0-fold for men 
[95% CL(0.8,1.3)] (a fold change of 1.0 indicates no difference between the 2 measures) (data 
not shown). At rest, the fold difference between these responses was 1.6-fold for both women 
[95% CL(1.2,2.0)] and men [95% CL(1.2,1.9)]. Thus the fold change observed in the synergistic 
response for stimulated GH AUC was dependent on condition (rest > exercise) (P < 0.001), but 
independent of gender (P = 0.7). Figure 5 (box plot) summarizes the difference data for the test 
of nonadditivity for stimulated GH AUC during rest and exercise. The incremental change in the 
synergistic (AG) response at rest compared with exercise was 1.4-fold [95% CL(1.1,1.8)] for 
women and 1.6-fold [95% CL(1.2,2.0)] for men. These differences were highly significant (P = 
0.007 and P = 0.001 in women and men, respectively). 
 
 
Fig. 5. Box plot representations of the nonadditivity (synergism) of the joint vs. single A and G 
stimuli. Data are logarithms of the differences between AG (combined A and G infusions) and 
the summed effects of A and G individually (A + G) at rest and during exercise for 3-h 
stimulated GH AUC. ○, Measurements below the 10th or above the 90th percentile. 
 
Analogously, during exercise the test for nonadditivity for 90-min GH secretory burst mass 
revealed that the combined stimulus (AG) was synergistic compared with the summed individual 
effects of A and G (A + G) (P = 0.02). The response to AG was 0.9-fold greater than the 
summed effects of (A + G) in exercising women [95% CL(0.67,1.2)] and 1.2-fold for men [95% 
CL(0.9,1.65)] (data not shown). At rest, the fold difference between these responses was 1.3-fold 
for women [95% CL(1.0,1.7)] and 1.5-fold for men [95% CL(1.1,2.0)] (companion paper, 
Ref. 43). Thus there was a trend for the fold change in synergy for 90-min GH secretory burst 
mass to depend on condition (rest > exercise) (P = 0.06), but not on gender (P = 0.14). The 
incremental changes in the synergistic response at rest compared with exercise were 1.5-fold 
[95% CL(1.0,2.2)] in women and 1.2-fold [95% CL(0.8,1.8)] in men (Figure 6). This comparison 
was nonsignificant for men and women. 
 
ANCOVA revealed that during exercise (as at rest; companion paper, Ref. 43), the linear 
relationship between log (basal serum GH AUC) and log stimulated (GH AUC) varied 
depending on stimulus administered. The relationship between these two variables had a positive 
slope for the S, A, and AG stimuli, but not for G (results not shown). Whereas substantial 
residual variance was explained by log(basal serum GH AUC), it failed to change the 
composition of the terms judged to be important in the original ANOVA model. 
 
With exercise, the calculated GH half-life was higher after the G and AG stimuli compared with 
the control (S) or A stimuli. The estimated half-life of GH was maximal in women for exercise 
combined with the AG stimulus (21 min) and in men for exercise and the G stimulus (20 min) 
(Table 2). The apparent GH half-life was dependent on the stimulus administered (P < 0.001) 
and serum GH concentration attained, but independent of gender (P = 0.956) and condition (rest 
vs. exercise, P = 0.537). Power function (y = axb) regression analysis of maximal serum GH 
concentrations (independent variable) on GH half-life (dependent variable) in men and women 
revealed significant curvilinear relationships (P < 0.001) (Figure7). There was no gender 
difference in these relationships. 
 
 
Fig. 6. Analog nonadditivity test for A/G synergism applied to 90-min GH secretory burst mass 
(see Fig. 5). ○, Measurements below the 10th or above the 90th percentile. 
 
 
Fig. 7. Power function (y = axb) regression analysis of the data from all 9 men and 9 women. 
Regressions relate the mean (±SE) maximal serum GH concentrations attained after various 
stimuli (x-axis) to the mean (±SE) calculated half-lives of endogenous GH (min,y-axis). The 
power-function fits were significant (P < 0.001) in both sexes, with no evident gender 
differences. 
 
DISCUSSION 
 
A major finding of the current investigation in men and women is that A and G interact 
synergistically in driving GH secretion even during exercise. Indeed, the fold change observed 
for the combined AG stimulus over control (S) was greater during exercise than at rest. In 
addition, during exercise the rank order of the GH secretory responses remains AG > G > A > S 
as recognized earlier in humans studied at rest (companion paper, Ref. 43). Moreover, exercise 
potentiated all measures of GH secretion compared with rest. Last, the timing of the maximal 
serum GH concentration attained during exercise showed a greater delay in men than women, as 
observed earlier at rest. 
 
Exercise of appropriate intensity and duration serves as a powerful physiological stimulus to GH 
release (22, 31, 35, 41, 42,44). Akin to the response nonuniformity inherent in other recognized 
GH secretagogues (18), the exact magnitude of the exercise response is variable among 
individuals (22, 23,42). Although some studies have reported gender differences in exercise-
induced GH release (8, 14), other studies have reported exercise-driven GH release to be 
independent of gender (23, 44). In this regard, we achieve statistically indistinguishable total 
energy expenditure and total work during constant-load exercise among all the stimuli studied 
here, which thus eliminates unequal exertion as a source of variability. The last consideration is 
important experimentally, because we recently demonstrated that the mass of GH secreted in 
response to a 30-min exercise stimulus is linearly proportional to exercise intensity (30). 
Although men attained greater absolute maximalV˙o2 rates at the end of exercise (as expected), it 
is unlikely that the gender differences observed in GH secretion are related to this distinction, 
because men and women achieved a similar relative V˙o2(∼73.5%) and end exercise 
V˙o2expressed per kilogram fat-free mass was not different between men and women. 
 
Exercise potentiated the maximal serum GH concentration attained after each secretagogue, 
compared with responses to the same secretagogue given at rest. The GH secretory response 
patterns after each stimulus were similar in men and women both during exercise 
(Figure 1,A and B) and at rest (companion paper, Ref. 43). Similar to previous reports (11, 37), 
women exhibited higher mean morning fasting baseline serum GH concentrations before the 
administration of any stimulus compared with men. Therefore, the fold increase in the peak 
serum GH concentration in response to exercise combined with A and G in men was 
approximately twice that in women; e.g., at rest 30- vs. 15-fold for men and women, 
respectively, and during exercise 48- vs. 23-fold for men and women, respectively, reflecting the 
relatively lower baseline serum GH concentrations in men. Thus, whereas men maintain lower 
mean baseline serum GH concentrations (and lower basal GH secretion rates) than women, the 
maximal absolute serum GH concentration attained in response to the exercise stimulus 
combined with a secretagogue (G and/or A) is similar in men and women, indicating a greater 
capacity for stimulated GH release in men. These results are similar to Bunt et al. (8), who 
reported that despite similar absolute maximal GH values for men and women, men had an 
approximately twofold greater increase in GH concentration compared with women in response 
to an exercise stimulus of 60% maximal V˙o2. This finding was maintained regardless of the 
training status of the individual (8). 
 
The integrated serum GH concentration (AUC) over 6 h was used as a complementary and 
statistically robust measure of total GH release. Similar to the maximal serum GH concentration, 
GH AUC rose significantly further in response to exercise combined with A, G, or AG compared 
with the response to each (corresponding) stimulus alone. This observation points to the novel 
nature of the exercise stimulus in the human (22, 31, 35, 41, 42, 44). Remarkably, exercise 
potentiated even the absolute GH response observed when A and G were coadministered. We 
reported earlier that at rest, the coadministration of A and G resulted in a 24- and 11-fold rise in 
GH AUC above basal (saline) in men and women, respectively. Exercise potentiated this effect 
in both men and women. In view of the twofold lower basal GH secretion rates in men, the 
fractional (fold) increase in GH AUC in AG-treated exercising men (31-fold, expressed relative 
to basal) was also approximately two times larger than that in women (15-fold). However, 
absolute measures of GH release driven by the threefold stimuli of A, G, and exercise in 
combination were equivalent in the two sexes, suggesting gender-independent maximal pituitary 
GH secretory capacity. 
 
As a more direct measure of the immediate hypothalamopituitary secretory response to the 
foregoing agonists, we calculated 90-min GH secretory burst mass. This value encapsulates all 
GH release immediately after any given stimulus while obviating the effects of unequal GH half-
lives, spurious spontaneous GH release at later times in the sampling session, and variable GH 
concentrations in the blood before secretagogue infusion (38). According to this reasoning, the 
90-min GH secretory burst mass may best represent the actual GH secretory response 
independent of differences in recovery of spontaneous GH pulsatility, GH half-life, and/or 
prestimulus GH levels. With this metric, we tested the hypothesis that the predominant 
mechanism of exercise-induced GH release involved withdrawal of hypothalamic somatostatin. 
To this end, we assessed the impact of the A stimulus alone, exercise alone, and their 
combination on the 90-min GH secretory burst mass. This strategy reflects current inference that 
A (via muscarinic, cholinergic, or unknown mechanisms) restrains hypothalamic somatostatin 
release (17). If the sole mediator of exercise-induced GH release were somatostatin withdrawal, 
then A combined with exercise would result in no further increase in 90-min GH secretory burst 
mass above that of each stimulus alone. Conversely, a contributory role for GHRH (or other 
secretagogues) would be implied by significant interactive amplification of GH release by A and 
exercise (18). Under these assumptions, data from the current investigation indicate that the 
mechanism of exercise-induced GH release mimics at least in part, the action of A, because the 
90-min GH secretory burst mass was similar in response to A infusion and exercise alone; 
moreover, combined A infusion and exercise did not significantly potentiate GH release. Several 
mechanistic considerations could explicate these findings. First, in several studies, β-adrenergic 
stimulation of somatostatin release was able to overcome the ability of A (or pyridostigmine) to 
increase GH secretion (15, 16). Exercise likely activates several central nervous system 
neurotransmitter pathways, including the adrenergic, cholinergic, and opioid systems 
(26, 35, 36). Given that exercise stimulates adrenergic outflow (34, 36, 39), we speculate that 
this inhibitory neurotransmitter response may oppose in part the stimulatory impact otherwise 
achieved by exercise or A. The approximate doubling of absolute 90-min GH secretory burst 
mass by A plus exercise vs. exercise alone in each sex (from 30 to 70 for women and 15 to 41 for 
men) (Fig. 4) would point to this possible explanation; i.e., A infusion partially overcomes the β-
adrenergic (or other) inhibition otherwise induced by exercise itself. 
 
Measures of 6-h GH AUC suggest additional mechanistic insights. A alone and exercise alone 
elicited similar GH release over 6 h, but A combined with exercise evoked a significantly greater 
GH AUC than exercise alone. This also suggests that A and exercise do not release GH 
exclusively via the same mechanism. We note that 6-h GH AUC and 90-min GH secretory burst 
mass provide complementary measures of GH axis activity. For example, the calculated GH 
AUC is influenced by GH half-life, whereas the 90-min GH secretory burst mass is corrected for 
GH half-life variations. More importantly perhaps, the calculated GH AUC encapsulates the 
entire 6 h of data collection and, therefore, could be modulated by differences in GH 
autofeedback emerging >90 min after the secretagogue/exercise stimulus. This consideration is 
of interest, because A demonstrably blunts GH-induced inhibition of GH release (18). We 
speculate that the positive interaction between A and exercise on 6-h GH AUC may thus reflect 
A-mediated suppression of GH autofeedback. 
 
Because we did not infuse GHRH in the present investigation, we cannot comment directly on 
the role of GHRH in exercise-induced GH release. However, several studies have shown that 
GHRP and GHRH typically act synergistically to stimulate GH release in humans 
(4, 6, 7, 28, 29). In addition, GHRP infusion promotes GHRH secretion in the sheep (13, 19). 
Thus enhancement of G action by exercise could reflect exercise and/or G's potentiation of 
endogenous GHRH release. 
 
Addition of A did not further amplify the 90-min GH secretory burst mass stimulated by G 
combined with exercise. This new observation could signify that 1) somatostatin release is 
minimal during the G plus exercise stimulus and/or 2) near-maximal stimulation of pituitary GH 
secretion is achieved by G alone, with or without corelease of endogenous GHRH. In addition, 
GHRPs can partially oppose the actions of somatostatin (33), in which circumstance the addition 
of A might exert little further effect. Alternatively, these collective issues could be harmonized 
by the thesis that A might act via nonsomatostatinergic pathways. Whereas exercise alone 
stimulates some somatostatin restraint of GH release, coadministration of G during exercise 
opposes this effect, thus 1) achieving a synergy between exercise and G and 2) limiting yet 
further potentiation by A during triple-secretagogue drive. 
 
In the experimental animal, hypothalamic GHRH can stimulate somatostatin release, whereas 
somatostatin inhibits GHRH secretion (3, 12, 20, 24, 45). Thus A might heighten the effect of 
exercise alone by reducing somatostatin's suppression of GHRH release (18). Analogously, 
GHRP's reported antagonism of somatostatin's action (above) could potentiate the exercise 
effect. Both of these models would predict that the threefold stimulation (AG and exercise) 
would not interact further, as indeed observed here. 
 
In men, A augmented the joint stimulatory effects of exercise and G on endogenous (6 h) GH 
production rate (summed pulse mass) over S control. This gender difference could indicate that 
GH secretion in women is less susceptible to GH (auto) feedback, which might be expressed 
over the 6-h observation interval (but not necessarily within the first 90 min). This perspective 
would be consistent with gender differences in GH autofeedback in the rat (10) and with the 
ability of A to limit GH autofeedback in the human presumptively via somatostatin withdrawal 
(18). 
 
Conversely, somatostatin infusions in the human strongly suppress GH pulse mass (9). Thus a 
gender difference in somatostatin withdrawal by A is a relevant consideration in explicating the 
more marked GH secretory output of men in this unique triple-secretagogue setting. 
 
Combined (joint) AG stimulation remained synergistic during exercise compared with the 
summed effects of separate A and G infusions (A + G) during exercise (P = 0.02). Possible 
mechanisms for this synergistic effect, as initially observed at rest, are outlined in the companion 
paper (43). In addition, we now show that the magnitude of this synergism tends to decrease with 
exercise (Fig. 6) (P = 0.06); i.e., the foregoing joint response was 1.2- to 1.5-fold greater during 
rest than exercise in men and women, respectively. The lesser synergy between A and G during 
exercise than at rest could indicate that exercise drives elements in the GH response pathway(s) 
that are already activated by A and/or G. Alternatively, exercise might evoke near-maximal GH 
secretion and/or unrecognized secondary neuroregulatory effects that partially antagonize the 
joint effects of A or G. 
 
The tendency of the synergy between A and G to be blunted by exercise was especially 
conspicuous in men and women in relation to the 3-h GH AUC (vs. 90-min GH secretory burst 
mass). This finding could indicate first that additional GH secretion occurs after 90 min 
especially in women, e.g., because of purported sex differences in GH autofeedback (see 
companion paper, Ref. 43). Second, the combined AG stimulus and exercise may have altered 
basal GH release in opposite directions. Present methods of secretory pulse analysis cannot 
readily address the latter speculations, because underlying basal (nonpulsatile) GH secretion is 
difficult to quantitate during massive GH outpouring. Last, because AUC calculations are also 
influenced by GH half-life (32), we compared the latter in men and women in response to these 
joint stimuli. A power function regression of GH half-life against GH concentration was 
statistically identical in men and women (Fig. 7), thus excluding this notion. 
 
In summary, exercise potentiates the individual and joint stimulatory actions of A and G in both 
men and women. We postulate that exercise stimulates GHRH secretion and partially restrains 
further GH release (e.g., by activating endogenous adrenergic and somatostatinergic outflow); A 
facilitates the effects of exercise by limiting somatostatin release, and G enhances the stimulatory 
effect of exercise by heightening endogenous GHRH release and/or by opposing central actions 
of somatostatin. Last, compared with rest, exercise blunts the relative (but not absolute) 
magnitude of the synergy between A and G, suggesting a novel threefold neuroendocrine 
interaction among these distinct stimuli. 
 
Perspectives 
 
Several gender differences emerged under the physiological stimulus of exercise. Men have a 
greater fold change in GH secretion compared with women in response to exercise. Women 
attain a maximal GH concentration more rapidly than men under exercise drive. The precise 
biological significance of these response differences to the target tissue is still unknown. 
However, the greater reliance of women on fat metabolism during exercise might relate to the 
foregoing contrasts. In absolute terms, near-maximal secretion of GH achieved by triple 
stimulation with A, G, and exercise was evidently gender independent. These distinctions might 
arise if exercise evokes multiple and complementary neuroregulatory responses by the GH axis. 
Such an inference is consistent with the unique ability of exercise to enhance GH secretion more 
than either secretagogue alone or combined. This threefold interaction allows for the conjecture 
that exercise recruits nonsomatostatinergic, non-GHRH, and non-GHRP-dependent pathways of 
cosecretagogue outflow as well. The nature of such ancillary stimulatory pathways is not known. 
On the other hand, relief of coinhibitory factors would also explicate the present data, because 
exercise facilitated the synergistic action of G and A. The unexpected ability of exercise to blunt 
the relative magnitude of the synergistic action of A and G achieved at rest also supports a 
putative multifold impact of exercise on GH neuroregulation. For example, other recent exercise 
studies have suggested that exercise may be a unique stimulus in overriding GH auto-negative 
feedback, possibly independent of gender. Accordingly, the novel and manifold GH-stimulating 
nature of exercise makes this intervention both an investigative challenge and an excellent 
clinical tool for evaluating the GH hypothalamopituitary axis. Additionally, exercise might be 
meritoriously combined with other secretagogues in enhancing GH output, because this stimulus 
appears to effect GH secretion at multiple levels. 
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